Ambroxol, a repurposed drug known for respiratory disease treatment, may become an important therapy for those with a mutation on the glucocerebrosidase gene (GBA) that increases one’s risk to develop PD [59]. The gene discussed is GBA1; the disease is Parkinson disease.